NeonatalAI

Precision for Every Newborn’s Future

Who Are We & What’s Our Mission?

Newborn bloodspot screening is vital for early detection of rare genetic disorders, improving survival rates by up to 70%

Learn more

But 2-10% of dried blood spot (DBS) samples are invalid, causing delays that can cost lives. That’s over 13 million babies affected globally each year.

Learn more

BlueBio is Here to Change That.
We’re committed to reducing screening errors and delays by transforming the way quality control is done — because every newborn deserves a healthy start.

Learn more

NeonatalAI: Precision in Every Step

Introducing…

The DBS Analyzer empowers nurses, hospitals, labs, and parents with next-generation accuracy, using advanced computer vision and machine learning to catch errors before they become problems.

Just snap a photo of the DBS sheet using a digital device or our dedicated hardware to check quality, and send it off for testing. It’s that simple.

Fast, reliable, and precise — every time.

Contact Us